comparemela.com

Latest Breaking News On - Regulationst rule - Page 29 : comparemela.com

Taiwan Semiconductor Manufacturing : TSMC Statement on April 3rd Earthquake - Form 6-K -April 03, 2024 at 11:16 am EDT

Document 1934 Act Registration No. 1-14700 UNITED.

United statesPingdong xianWendell huangSecurities exchangeCommission file numberTaiwan semiconductor manufacturing company ltdName into englishScience parkPrincipal executive officesRegulationst ruleSecurities exchange actVice presidentChief financial officer

BHP : Appointment of Ross McEwan - Form 6-K -April 03, 2024 at 07:50 am EDT

FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K .

United statesSecurities exchangeRegulationst ruleSecurities exchange act

Perfect : Director Resignation - Form 6-K -April 02, 2024 at 06:24 am EDT

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 .

T ai peiUnited statesTainan municipalityJianmei lyuAliceh changPerfect corpCommission file numberSecurities exchangeFile numberTaipei cityRegulationst ruleSecurities exchange act

Honda Motor : Notice Concerning Status of Acquisition of the Company s Own Shares (Acquisition of the Company s own shares pursuant to the Articles of Incorporation of the Company in accordance with Article 459, Paragraph 1 of the Company Law) - Form 6-K -April 02, 2024 at 06:09 am EDT

Form 6-K No.1-7628 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K .

Minami aoyamaMinato kuUnited statesRegulationst rule

AstraZeneca : Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with the rare disease PNH - Form 6-K -April 02, 2024 at 08:48 am EDT

a9026i FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

University of washington medical centerUnited statesUnited kingdomGlasgow cityMarc dunoyerAdrian kempBart scottDivision of hematologyEuropean hematology associationSecurities exchangeCompany secretaryEuropean medicines agencyInvestor relations teamCommission file numberAlexion pharmaceuticals incEuropean union

vimarsana © 2020. All Rights Reserved.